Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

July 31, 2001

Study Completion Date

December 31, 2001

Conditions
Smoking Cessation
Interventions
DRUG

Nasal Spray Nicotine Substitute (Experimental)

During the first month, subjects in the intervention group received instruction from the physician to use NNS regularly (at least 2 puffs/hour, for an average of 1 mg nicotine/hour when awake).

DRUG

Nasal Spray Nicotine Substitute (ad libitum)

In the control group, participants were instructed to use NNS as needed to suppress withdrawal symptoms when cravings appeared.

Trial Locations (1)

1011

Department of Ambulatory Care and Community Medicine, Lausanne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pharmacia

INDUSTRY

lead

University of Lausanne

OTHER

NCT00861276 - Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit | Biotech Hunter | Biotech Hunter